Record Net Revenue
Tilray achieved a record net revenue of $210 million for Q1 fiscal year 2026, representing a 5% increase year-over-year.
Strengthened Balance Sheet
Reduced outstanding debt by $7.7 million and maintained a net debt-to-EBITDA ratio of 0.07x, with cash and cash equivalents totaling $265 million.
Growth in Cannabis Segment
Cannabis revenue grew 5% year-over-year to $65 million, with Canadian Adult-Use and International Cannabis business delivering 12% and 10% growth respectively.
Expansion in International Markets
International cannabis revenue grew 10% to $13.4 million, with strategic growth plans to triple the medical cannabis distribution footprint in Germany.
Beverage Business Turnaround
Project 420 resulted in $25 million in annual savings, with notable growth in brands like Shock Top, which saw a 49% increase in dollar sales in the Southeast.